Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults-Reference-Cited by-同舟云学术

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults

Published:2018-11-08 Issue:4 Volume:144 Page:707-717
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

McGee Emma E.¹^ORCID,Castro Felipe A.¹²,Engels Eric A.¹,Freedman Neal D.³,Pfeiffer Ruth M.⁴,Nogueira Leticia¹⁵,Stolzenberg-Solomon Rachael³,McGlynn Katherine A.³^ORCID,Hemminki Kari⁶⁷,Koshiol Jill¹

Affiliation:

1. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville MD

2. Real World Data Science (RWD-S) Oncology; Roche Basel Switzerland

3. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville MD

4. Biostatistics Branch; Division of Cancer Epidemiology and Genetics; National Cancer Institute, Rockville MD

5. American Cancer Society; Atlanta GA

6. Division of Molecular Genetic Epidemiology; German Cancer Research Center (DKFZ); Heidelberg Germany

7. Center for Primary Health Care Research; Lund University; Malmö Sweden

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31835/fullpdf

Reference50 articles.

1. Biliary Tract Cancer

2. Hepatocellular carcinoma;Forner;Lancet,2012

3. Gallbladder cancer incidence and mortality, United States 1999-2011;Henley;Cancer Epidemiol Biomarkers Prev,2015

4. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J Clin Oncol,2009

5. Changing pattern of epidemiology in intrahepatic cholangiocarcinoma;Njei;Hepatology,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy;Current Cancer Drug Targets;2024-11

2. Antibodies against endogenous retroviruses;Immunological Reviews;2024-08-17

3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer;ESMO Open;2024-08

4. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis;Clinical and Molecular Hepatology;2024-04-01

5. Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk;Hepatology Communications;2023-08-09